EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

A sporozoite-based vaccine for Theileria parva






Parasitology Today 9(10): 385-388

A sporozoite-based vaccine for Theileria parva

East Coast fever, which is caused by Theileria parva infection in cattle, is of major economic importance in eastern and central Africa. Until recently, the only available method of immunization against East Coast fever was the infection with live sporozoites and simultaneous treatment with a long-acting oxytetracycline. This method has two major disadvantages: (I) it uses live organisms; and (2) the immunity engendered is parasite strain specific. In this article, Antony Musoke, Vishvonath Nene and Subhosh Morzoria review the progress made in developing an alternative method o f immunization based on a defined sporozoite antigen.

Accession: 002289053

PMID: 15463675

DOI: 10.1016/0169-4758(93)90089-x

Download PDF Full Text: A sporozoite-based vaccine for Theileria parva



Related references

Development of a novel subunit vaccine against East Coast fever based on the Theileria parva sporozoite surface protein p67. Development of a novel subunit vaccine against East Coast fever based on the Theileria parva sporozoite surface protein p67: vi + 120 pp., 2003

Immunization with theileria parva parasites from buffaloes results in generation of cytotoxic t cells which recognize antigens common among cells infected with stocks of theileria parva parva theileria parva bovis and theileria parva lawrencei. Infection & Immunity 58(11): 3574-3581, 1990

Attenuated Salmonella dublin vaccine expressing a sporozoite protein protects against Theileria parva. Schweizerische Medizinische Wochenschrift 127(39): 1621, Sept, 1997

Characterization of an insect cell-derived Theileria parva sporozoite vaccine antigen and immunogenicity in cattle. Infection and Immunity 63(2): 503-508, 1995

Conservation of the sporozoite p67 vaccine antigen in cattle-derived Theileria parva stocks with different cross-immunity profiles. Infection and Immunity 64(6): 2056-2061, 1996

Molecular characterization of live Theileria parva sporozoite vaccine stabilates reveals extensive genotypic diversity. Veterinary Parasitology 179(1-3): 62-68, 2011

The genomes of three stocks comprising the most widely utilized live sporozoite Theileria parva vaccine exhibit very different degrees and patterns of sequence divergence. Bmc Genomics 16(): 729-729, 2016

Linear peptide specificity of bovine antibody responses to p67 of Theileria parva and sequence diversity of sporozoite-neutralizing epitopes: implications for a vaccine. Infection and Immunity 67(3): 1261-1266, 1999

Conservation of neutralizing determinants between the sporozoite surface antigens of Theileria annulata and Theileria parva. Experimental Parasitology 82(3): 229-241, 1996

Reciprocal cross-protection induced by sporozoite antigens SPAG-1 from Theileria annulata and p67 from Theileria parva. Parasite Immunology 22(5): 223-230, 2000